Subscribe
megaflopp / Shutterstock.com
23 July 2024NewsAmericasLiz Hockley

US targets ‘product hopping’ with biologic litigation curbs

House of Representatives introduces bill to drive down cost of prescription drugs | Places “reasonable limit” on the number of patents a manufacturer can contest to prevent patent ‘thickets’ | Companion bill passed Senate earlier this month.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FTC supports USPTO terminal disclaimer plan amid opposition
11 July 2024   Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation.
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024   As SCOTUS pulls away from deference to federal agencies, issues such as non-competes and terminal disclaimers could be on shaky ground, finds Muireann Bolger.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Americas
FTC supports USPTO terminal disclaimer plan amid opposition
11 July 2024   Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation.
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024   As SCOTUS pulls away from deference to federal agencies, issues such as non-competes and terminal disclaimers could be on shaky ground, finds Muireann Bolger.

More on this story

Americas
FTC supports USPTO terminal disclaimer plan amid opposition
11 July 2024   Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation.
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024   As SCOTUS pulls away from deference to federal agencies, issues such as non-competes and terminal disclaimers could be on shaky ground, finds Muireann Bolger.

More features

Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
Novo Nordisk files fresh lawsuits to intercept Wegovy generics
HLK adds CRISPR specialist as partner
UPC delivers first 'imminent infringement' decision in biosimilar dispute